Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity A Report by the American Academy of Ophthalmology

VanderVeen Deborah K.; Melia Michele; Yang Michael B.; Hutchinson Amy K.; Wilson Lorri B.; Lambert Scott R.

首页> 外文期刊>Ophthalmology >Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity A Report by the American Academy of Ophthalmology

【24h】

Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity A Report by the American Academy of Ophthalmology

机译：抗血管内皮生长因子疗法用于初级治疗1型视网膜病变的早产儿美国眼科学院的报告

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To review the available evidence on the ocular safety and efficacy of anti-vascular endothelial growth factor (VEGF) agents for the treatment of retinopathy of prematurity (ROP) compared with laser photocoagulation therapy.

机译：目的：与激光光凝治疗相比，审查抗血管内皮生长因子（VEGF）药物治疗早熟（ROP）视网膜病变的眼部安全性和疗效的可用证据。

著录项

来源
《Ophthalmology》 |2017年第5期|共15页
作者
VanderVeen Deborah K.; Melia Michele; Yang Michael B.; Hutchinson Amy K.; Wilson Lorri B.; Lambert Scott R.;
展开▼
作者单位

Harvard Med Sch Boston Childrens Hosp Dept Ophthalmol Boston MA USA;

Jaeb Ctr Hlth Res Tampa FL USA;

Univ Cincinnati Coll Med Cincinnati Childrens Hosp Med Ctr Abrahamson Pediat Eye Inst Dept;

Emory Univ Sch Med Dept Ophthalmol Atlanta GA 30322 USA;

Oregon Hlth &

Sci Univ Casey Eye Inst Portland OR 97201 USA;

Stanford Univ Sch Med Dept Ophthalmol Stanford CA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity A Report by the American Academy of Ophthalmology [J] . VanderVeen Deborah K., Melia Michele, Yang Michael B., Ophthalmology . 2017,第5期

机译：抗血管内皮生长因子疗法用于初级治疗1型视网膜病变的早产儿美国眼科学院的报告
2. Safety and Efficacy of Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration A Report by the American Academy of Ophthalmology [J] . Bakri Sophie J., Thorne Jennifer E., Ho Allen C., Ophthalmology . 2019,第1期

机译：抗血管内皮生长因子治疗用于新生血管年龄相关性黄斑变性的安全性和有效性美国眼科学院的报告
3. Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: A report by the American academy of ophthalmology [J] . HoA.C., ScottI.U., KimS.J., Ophthalmology . 2012,第10期

机译：抗血管内皮生长因子药物治疗糖尿病性黄斑水肿：美国眼科学院的报告
4. Functional Materials: Functionalization of Ultrabithorax Materials with Vascular Endothelial Growth Factor Enhances Primary Human Endothelial Cell Survival and Activation [C] . David W. Howell, Camille Duran, Shang-Pu Tsai, . 2015

机译：功能材料：具有血管内皮生长因子的超胸腔材料的功能化增强了人类原代内皮细胞的存活和激活
5. Strategies in anti-angiogenic cancer therapy: Exploiting the role of vascular endothelial growth factor (VEGF) in tumor growth and endothelial cell survival. [D] . Wild, Robert Christian. 2000

机译：抗血管生成癌治疗的策略：利用血管内皮生长因子（VEGF）在肿瘤生长和内皮细胞存活中的作用。
6. Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP) [O] . Zijing Li, Yichi Zhang, Yunru Liao, 2018

机译：抗血管内皮生长因子（VEGF）和激光治疗1型和早产儿视网膜病变（ROP）的疗效比较
7. Refractive errors in premature infants with retinopathy of prematurity after anti-vascular endothelial growth factor (anti-VEGF) therapy [O] . Vujanović Milena S., Stanković-Babić Gordana Lj., Oros Ana, 2017

机译：抗血管内皮生长因子（抗VEGF）治疗后早产儿视网膜病变的早产儿屈光不正

Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity A Report by the American Academy of Ophthalmology

摘要

著录项

相似文献

相关主题

期刊订阅